![https://static.aminer.cn/upload/avatar/78/1184/600/53f430b1dabfaee1c0a5e14c_1.jpg](https://avatarcdn.aminer.cn/upload/avatar/78/1184/600/53f430b1dabfaee1c0a5e14c_1.jpg!160)
Hugh Markus
教授
Department of Clinical Neurosciences
University of Cambridge;BHF Cambridge Centre of Excellence, University of Cambridge;Cardiovascular Interdisciplinary Research Centre, University of Cambridge;Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge
关注
立即认领
分享
关注
立即认领
分享
基本信息
浏览量:427
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
I use molecular genetic and neuroimaging (MRI and Transcranial Doppler) techniques to investigate the pathogenesis of, and develop treatments for, cerebrovascular disease.
A particular interest is in cerebral small vessel disease, a major cause of stroke and the major cause of vascular cognitive impairment; here we are studying genetic determinants (for both monogenic and polygenic disease), the mechanisms of cognitive decline using advanced multimodal MRI, and evaluating new therapeutic approaches. Our imaging projects involve the application of MRI and PET to look at blood brain barrier leakage and glial activation (neuroinflammation in man, and the use of diffusion tensor MRI to determine how vascular damage leads to white matter damage and cognitive impairment.
I am involved in a number of international studies of stroke genetics including the WTCCC2 ischaemic stroke study which we led, METASTROKE which we established and MEGASTROKE all as part of the the International Stroke Genetics Consortium. I run a National clinical referral service for patients with the monogenic from of stroke CADASIL.
A particular interest is in cerebral small vessel disease, a major cause of stroke and the major cause of vascular cognitive impairment; here we are studying genetic determinants (for both monogenic and polygenic disease), the mechanisms of cognitive decline using advanced multimodal MRI, and evaluating new therapeutic approaches. Our imaging projects involve the application of MRI and PET to look at blood brain barrier leakage and glial activation (neuroinflammation in man, and the use of diffusion tensor MRI to determine how vascular damage leads to white matter damage and cognitive impairment.
I am involved in a number of international studies of stroke genetics including the WTCCC2 ischaemic stroke study which we led, METASTROKE which we established and MEGASTROKE all as part of the the International Stroke Genetics Consortium. I run a National clinical referral service for patients with the monogenic from of stroke CADASIL.
研究兴趣
论文共 818 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Fluids and Barriers of the CNSno. 1 (2024): 1-13
Alzheimer's & dementia : the journal of the Alzheimer's Associationno. 6 (2024): 3852-3863
Audrey Low, Sanne van Winden, Lupei Cai,Roy P. C. Kessels,Marnix C. Maas,Robin G. Morris,Meritxell Nus,Daniel J. Tozer,Anil Tuladhar,Anja van der Kolk, Rowan Wolters,Ziad Mallat,
BMJ openno. 2 (2024): e084303-e084303
Shadi Yaghi,Liqi Shu, Lauren Fletcher,Fayez H. Fayad,Asghar Shah,Ana Herning, Noail Isho, Perla Mansour,Kareem Joudi,Bashar Zaidat,Noor A. Mahmoud, Feras Abdul Khalek,
PubMed (2024)
INTERNATIONAL JOURNAL OF STROKE (2024)
Sarah McNeilly, Cameron R. Thomson, Laura Gonzalez-Trueba, Yuan Yan Sin, Alessandra Granata, Graham Hamilton, Michelle Lee, Erin Boland, John D. McClure, Cristina Lumbreras-Perales, Alisha Aman, Apoorva A. Kumar,
eBioMedicine (2024): 105315
Stephen Brennan,Peter J Kelly,Sarah Gorey,Pádraig Synnott,Dipender Gill,Martin Dichgans,Marios K Georgakis,Marie-Joe Dib,Eloi Gagnon, Niall Gerard Mahon,Gavin Blake,Christina Jern,
medrxiv(2024)
INTERNATIONAL JOURNAL OF STROKEno. 4 (2024): 376-378
Strokeno. 4 (2024): 934-942
加载更多
作者统计
#Papers: 821
#Citation: 54910
H-Index: 125
G-Index: 209
Sociability: 9
Diversity: 0
Activity: 6
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn